Molbio Diagnostics Limited (NSE:MOLBIO)
India · Delayed Price · Currency is INR 1,280.50
-32.70 (-2.49%)
Sep 24, 2026, 10:20 AM IST
Molbio Diagnostics Market Cap
Molbio Diagnostics has a market cap or net worth of 151.33 billion as of September 23, 2026.
Market Cap
151.33B
Enterprise Value
153.52B
Revenue
17.54B
Ranking
n/a
PE Ratio
59.44
Stock Price
1,280.50
ChartMarket Cap Chart
Since August 17, 2026, Molbio Diagnostics's market cap has increased from 120.05B to 151.33B, an increase of 26.06%. That is a compound annual growth rate of 882.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 151.33B | 3.91% |
| Sep 22, 2026 | 145.64B | 3.69% |
| Sep 21, 2026 | 140.45B | -5.39% |
| Sep 18, 2026 | 148.46B | 0.23% |
| Sep 17, 2026 | 148.12B | -1.66% |
| Sep 16, 2026 | 150.62B | -3.67% |
| Sep 15, 2026 | 156.36B | -5.66% |
| Sep 11, 2026 | 165.74B | -4.72% |
| Sep 10, 2026 | 173.94B | 19.99% |
| Sep 9, 2026 | 144.96B | 12.56% |
| Sep 8, 2026 | 128.78B | -0.86% |
| Sep 7, 2026 | 129.90B | -2.87% |
| Sep 4, 2026 | 133.74B | 2.23% |
| Sep 3, 2026 | 130.82B | 2.47% |
| Sep 2, 2026 | 127.66B | 5.17% |
| Sep 1, 2026 | 121.38B | -3.04% |
| Aug 31, 2026 | 125.19B | -0.77% |
| Aug 28, 2026 | 126.16B | -4.32% |
| Aug 27, 2026 | 131.85B | -7.64% |
| Aug 26, 2026 | 142.77B | 0.94% |
| Aug 25, 2026 | 141.44B | 2.34% |
| Aug 24, 2026 | 138.21B | 9.18% |
| Aug 21, 2026 | 126.59B | 5.96% |
| Aug 20, 2026 | 119.46B | - |
| Aug 19, 2026 | 119.46B | -6.68% |
| Aug 18, 2026 | 128.02B | 6.64% |
| Aug 17, 2026 | 120.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.48T |
| Divi's Laboratories | 2.50T |
| Apollo Hospitals Enterprise | 1.28T |
| Lenskart Solutions | 1.23T |
| Syngene International | 153.33B |
| Marksans Pharma | 153.21B |
| Rainbow Children's Medicare | 146.22B |
| NATCO Pharma | 146.21B |